Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality

Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality

Introduction The prevalence of atrial fibrillation (AF) in acute coronary syndrome (ACS) patients is increasing. Data on outcomes of anticoagulation in ACS patients with AF are lacking. Objectives The aim of our study was to investigate the prevalence of stroke, myocardial infarction, bleeding compl...

Full description

Bibliographic Details
Main Authors: Łukasz Pyka MD, PhD, Bartosz Hudzik MD, PhD, Stanisław Bartuś MD, PhD, Paweł Buszman MD, PhD, Marek Gierlotka MD, PhD, Wojciech Wojakowski MD, PhD, Jarosław Hiczkiewicz MD, PhD, Andrzej Kleinrok MD, PhD, Michał Skrzypek MD, PhD, Wiktor Kuliczkowski MD, PhD, Mariusz Gąsior MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2023-12-01
Series:Journal of Cardiovascular Pharmacology and Therapeutics
Online Access:https://doi.org/10.1177/10742484231212106

Internet

https://doi.org/10.1177/10742484231212106

Similar Items